Antares Pharma (United States)
The patient is at the forefront of everything we do at Halozyme. With our disruptive drug delivery technologies and robust commercial portfolio, we are committed to reinventing the patient experience by easing the burden of treatment and improving patient outcomes. Copyright© 2015-2024.
Basic Information
- Category: business
- Website: https://www.antarespharma.com/
Documented Facts
- Inception (Wikidata): 1978 (Source 2: Wikidata Q104479992, revision 2474513849)
- Country (Wikidata; date unspecified): United States (Source 2: Wikidata Q104479992, revision 2474513849; Source 3: Wikidata label: Q30, revision 2556188301)
- Official website (Wikidata; date unspecified): https://www.antarespharma.com/ (Source 2: Wikidata Q104479992, revision 2474513849)
Evidence and Sources
- Antares Pharma (United States) — Official Website (official)
- Wikidata Q104479992, revision 2474513849 (knowledge-base)
- Wikidata label: Q30, revision 2556188301 (knowledge-base)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Antares Pharma (United States).
- Canonical profile: https://brandsource.ai/brands/antares-pharma-united-states
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/antares-pharma-united-states/json-ld
- Citation profile API: https://brandsource.ai/api/brands/antares-pharma-united-states/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (91/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-21
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
The patient is at the forefront of everything we do at Halozyme. With our disruptive drug delivery technologies and robust commercial portfolio, we are committed to reinventing the patient experience by easing the burden of treatment and improving patient outcomes. Copyright© 2015-2024.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 2 supporting sources linked.
- 3 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.